Gilead Sciences Inc (GILD) Insider Trading
- $1,429,700.00
- $1,101,978,734.71
- May 22, 2025
- John C Martin
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Nov. 3, 2014 | CFO | 33,192 | $110.26 | Sell | $3,659,749.92 | |
| Nov. 3, 2014 | Director | 5,000 | $112.02 | Sell | $560,100.00 | |
| Nov. 3, 2014 | CEO | 140,625 | $110.40 | Sell | $15,525,000.00 | |
| Oct. 24, 2014 | EVP | 2,000 | $110.00 | Sell | $220,000.00 | |
| Oct. 7, 2014 | COO | 146,895 | $104.60 | Sell | $15,365,217.00 | |
| Oct. 1, 2014 | CEO | 140,625 | $105.91 | Sell | $14,893,593.75 | |
| Oct. 1, 2014 | EVP | 2,000 | $106.39 | Sell | $212,780.00 | |
| Oct. 1, 2014 | Director | 5,000 | $106.99 | Sell | $534,950.00 | |
| Sept. 26, 2014 | EVP | 2,000 | $107.47 | Sell | $214,940.00 | |
| Sept. 22, 2014 | Director | 5,000 | $106.60 | Sell | $533,000.00 | |
| Sept. 8, 2014 | COO | 146,895 | $105.99 | Sell | $15,569,401.05 | |
| Sept. 2, 2014 | EVP | 33,000 | $108.58 | Sell | $3,583,140.00 | |
| Sept. 2, 2014 | CEO | 140,625 | $108.64 | Sell | $15,277,500.00 | |
| Aug. 26, 2014 | EVP | 10,000 | $106.16 | Sell | $1,061,600.00 | |
| Aug. 25, 2014 | CFO | 4,304 | $105.87 | Sell | $455,664.48 | |
| Aug. 21, 2014 | Director | 5,000 | $101.09 | Sell | $505,450.00 | |
| Aug. 14, 2014 | CFO | 33,556 | $95.56 | Sell | $3,206,611.36 | |
| Aug. 1, 2014 | CEO | 140,625 | $91.53 | Sell | $12,871,406.25 | |
| Aug. 1, 2014 | EVP | 33,000 | $91.62 | Sell | $3,023,460.00 | |
| Aug. 1, 2014 | Director | 5,000 | $91.00 | Sell | $455,000.00 | |
| Aug. 1, 2014 | CFO | 30,600 | $91.48 | Sell | $2,799,288.00 | |
| July 28, 2014 | Director | 45,000 | $90.56 | Sell | $4,075,200.00 | |
| July 21, 2014 | Director | 5,000 | $89.67 | Sell | $448,350.00 | |
| July 8, 2014 | EVP | 16,728 | $86.45 | Sell | $1,446,135.60 | |
| July 1, 2014 | EVP | 33,000 | $84.12 | Sell | $2,775,960.00 | |
| July 1, 2014 | CEO | 140,625 | $84.84 | Sell | $11,930,625.00 | |
| July 1, 2014 | Director | 5,000 | $83.65 | Sell | $418,250.00 | |
| June 30, 2014 | CFO | 10,400 | $83.98 | Sell | $873,392.00 | |
| June 23, 2014 | Director | 5,000 | $81.82 | Sell | $409,100.00 | |
| June 16, 2014 | EVP | 90,000 | $80.90 | Sell | $7,281,000.00 | |
| June 9, 2014 | EVP | 16,728 | $79.43 | Sell | $1,328,705.04 | |
| June 4, 2014 | CFO | 6,426 | $82.52 | Sell | $530,273.52 | |
| June 2, 2014 | Director | 5,000 | $80.95 | Sell | $404,750.00 | |
| June 2, 2014 | EVP | 33,000 | $81.35 | Sell | $2,684,550.00 | |
| May 14, 2014 | EVP | 90,000 | $80.65 | Sell | $7,258,500.00 | |
| May 6, 2014 | CFO | 3,000 | $79.91 | Sell | $239,730.00 | |
| May 1, 2014 | CEO | 140,625 | $79.02 | Sell | $11,112,187.50 | |
| May 1, 2014 | CFO | 27,600 | $79.16 | Sell | $2,184,816.00 | |
| May 1, 2014 | Director | 5,000 | $78.63 | Sell | $393,150.00 | |
| May 1, 2014 | EVP | 13,000 | $79.08 | Sell | $1,028,040.00 | |
| April 14, 2014 | EVP | 90,000 | $67.03 | Sell | $6,032,700.00 | |
| April 8, 2014 | EVP | 16,728 | $70.53 | Sell | $1,179,825.84 | |
| April 8, 2014 | Director | 5,000 | $70.55 | Sell | $352,750.00 | |
| April 1, 2014 | CEO | 140,625 | $73.26 | Sell | $10,302,187.50 | |
| April 1, 2014 | EVP | 13,000 | $73.20 | Sell | $951,600.00 | |
| March 14, 2014 | EVP | 90,000 | $75.89 | Sell | $6,830,100.00 | |
| March 14, 2014 | Director | 14,000 | $76.44 | Sell | $1,070,160.00 | |
| March 10, 2014 | EVP | 16,728 | $79.32 | Sell | $1,326,864.96 | |
| March 3, 2014 | EVP | 33,000 | $81.84 | Sell | $2,700,720.00 | |
| March 3, 2014 | CEO | 140,625 | $81.74 | Sell | $11,494,687.50 |
Insiders are both buying and selling Gilead Sciences Inc stock.
The insider traders at Gilead Sciences Inc are: John C Martin, John Francis Cogan, Gregg H Alton, Brett A Pletcher, Paul Rutherford Carter, Robin L Washington, Andrew D Dickinson, John F Milligan, Merdad Parsey, Richard James Whitley, Norbert Bischofberger, John C. Martin, Norbert W Bischofberger, Gregg Alton, Gregg H. Alton, Johanna Mercier, Gayle E Wilson, John Martin, Olsen Per Wold, Diane E Wilfong, Nicholas Moore, Kevin Young, John F. Milligan, John W Madigan, Robin Washington, Norbert W. Bischofberger, James R Meyers, Jeffrey Bluestone, Javier Rodriguez, Kevin E Lofton, Diane E. Wilfong, Marjorie Taylor Greene, Nicholas G Moore, and Gayle E. Wilson
The most active insider trader at Gilead Sciences Inc is John C Martin with 41 trades.
John C Martin has sold the most Gilead Sciences Inc stock with a total value of $373,177,431.55.
Olsen Per Wold has bought the most Gilead Sciences Inc stock with a total value of $2,428,900.00.
The most recent insider trade for Gilead Sciences Inc was on May 22, 2025.
The single biggest insider buy for Gilead Sciences Inc was from Olsen Per Wold with a total value of $999,200.00 on Feb. 6, 2015.
The single biggest insider sell for Gilead Sciences Inc was from Andrew D Dickinson with a total value of $23,064,310.20 on Nov. 29, 2024.